Seres Therapeutics, Inc. ( MCRB) - Stock Earnings
MCRB Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 8.2 million USD | 351000 USD |
| 2025Q4 | -15.3 million USD | 438000 USD |
| 2026Q1 | -19.9 million USD | 358000 USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
MCRB Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -113.7 million USD | 126.3 million USD |
| 2024 | 136000 USD | — USD |
| 2025 | 5.7 million USD | 789000 USD |
| 2026 Est. | — | — |
MCRB
Price: $6.61
52 week price:
Earnings Per Share: -5.20 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 536116
Ebitda: -5.4 millionMarket Capitalization: 69.7 million